Serezani and Sun named associate scientific advisors to Science Translational Medicine
Mar. 20, 2014
C. Henrique Serezani, Ph.D., and Jie Sun, Ph.D., of the IU School of Medicine, have been selected to serve as associate scientific advisers to the scientific journal Science Translational Medicine, a sister publication of the journal Science.
Dr. Serezani is an assistant professor of microbiology and immunology. His primary research interest is the advancement of treatments for Methicillin-resistant staphylococcus aureus, or MRSA, a highly drug-resistant bacterium that kills hundreds of at-risk hospital patients across the country each year. There are very few treatments for the bacteria, which not only causes a variety of serious skin infections but is also the No. 1 cause of gastroenteritis.
He holds a doctorate, master's and bachelor's degrees from Sao Paulo University in Sao Paulo, Brazil. He also served as a postdoctoral fellow in the division of pulmonary and critical care medicine at the University of Michigan at Ann Arbor.
Dr. Sun is an assistant professor of pediatrics and of microbiology and immunology and a member of the Herman B Wells Center for Pediatric Research. His primary research interest is the regulation of immune response during acute respiratory virus infection, including the influenza virus and human respiratory syncytial virus, or RSV, a major cause of lower respiratory tract infections and hospital visits during infancy and childhood.
He holds a doctorate from the University of Pennsylvania, a Master of Science from the Chinese Academy of Preventive Medicine and a bachelor's degree from Sichuan University in China.
He also served as a postdoctoral researcher at the University of Virginia, where he also served as an assistant research professor for one year before joining IU.
Science Translational Medicine, established in 2009, is an interdisciplinary medical research journal established by the journal Science and the American Association for the Advancement of Science. It aims to advance the field of translational medicine, which promotes the transfer of basic science discoveries and experimental approaches of modern science to the alleviation of human disease -- a goal which the journal states continues to elude biomedical science despite 50 years of advances in the fundamental understanding of human biology and the emergence of powerful new technologies.